Explain the disparities in price levels (and not mere poverty) that are key to accessing some drugs in the global markets. These disparities mean that a Tanzanian worker would have to earn 500 hours of wages to get a course of first-line tuberculosis treatment, compared with the one hour of wages necessary for a Swiss worker. Give your researched findings on these types of situations and your solutions.
Prescription drugs are becoming more expensive with time. New medication requires of new technological research and such costs are transferred directly to the patient through higher cost share (Kleine, 2001). This becomes a problem when the person cannot access the medication for its high cost or because he/she has other priorities essential to life that take precedent over paying for medication.
The effect of medication cost can have in a person diagnosed with attention-deficit/hyperactivity disorder (ADHD) is extremely particular and interesting to discuss. This chronic illness has become an important public health problem because it affects school performance and socialization, increases lost days at work, and does not have a treatment intervention that have long term substantial benefits (Center for Disease Control [CDC], 2010b). More than 60% of the persons diagnosed receive medication and in 2005, it was estimated that each person affected with ADHD had annual costs between $12k and $16K (CDC, 2010a; Scheffler, Hinshaw, Modrek, & Levine, 2007). With new formulations of longer-acting stimulants and nonstimulant agents coming out each time, those costs will ...
The solution involves a discussion on how disparities in price levels and other key factors can influence not only accessibility but compliance with treatment. It discusses as an example ADHD treatment and gives possible solutions to increase accessibility to medication in general.